According to FutureWise analysis the market for continuous positive airway pressure devices in 2023 is US$ 2.43 billion, and is expected to reach US$ 3.83 billion by 2031 at a CAGR of 5.80%.
Continuous positive airway pressure treatment is prominently used for treating obstructive sleep apnea using constant air pressure. These devices keep the airways open during sleep and it is used for controlling the output pressure by maintaining the airflow pressure. Furthermore, the rising occurrence of sleep disorders owing to a stressful lifestyle shall bolster the continuous positive airway pressure devices market growth.
According to the CDC, over 340 million people across the world are diagnosed with sleep apnea. Such a growing awareness related to comorbid conditions like high blood pressure shall boost the market growth substantially. Continuous positive airways in nasal form is used on infants regularly and they are also recommended to be used every night. Some patients often complain about nasal and throat dryness, mask discomfort while using CPAD devices. Other users find it complicated to use especially while travelling. Such problems shall reduce the usage of these devices by patients leading to the impediment of the market growth.